金城医药：注射用头孢呋辛钠收到药品补充申请批准通知书

Core Viewpoint - Jincheng Pharmaceutical (300233.SZ) announced that its subsidiary, Guangdong Jincheng Jinsu Pharmaceutical Co., Ltd., received approval from the National Medical Products Administration for the supplemental application of injectable Cefuroxime Sodium, a proprietary drug of the company [1] Group 1: Product Information - Injectable Cefuroxime Sodium is a proprietary drug (reference formulation) produced using technology and raw materials from ACS DOBFAR S.P.A [1] - The drug is primarily indicated for infections caused by bacteria sensitive to Cefuroxime, including respiratory and ENT infections, urinary tract infections, skin and soft tissue infections, sepsis, meningitis, and bone and joint infections [1] - Additionally, this product can be used for infection prevention before or during surgical procedures, such as abdominal, pelvic, orthopedic, cardiac, pulmonary, esophageal, vascular, and total joint replacement surgeries [1]